ENVERIC BIOSCIENCES, INC. Total Long-Term Debt
ENVERIC BIOSCIENCES, INC. (ENVB) had Total Long-Term Debt of $740.34 thousand as of 2019-12-31, per its 10-K filed 2021-04-01.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2021-04-01
- 2019-12-31: Long-term Debt $740.34K.
- 2018-12-31: Long-term Debt $6.45K.
- 2017-12-31: Long-term Debt $1.88M.
- 2016-12-31: Long-term Debt $1.94M; Long-term Debt as first filed $1.54M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2019-12-31 | $740.34K 10-K · filed 2021-04-01 | |
| 2018-12-31 | $6.45K 10-K · filed 2019-03-26 | |
| 2017-12-31 | $1.88M 10-K · filed 2019-03-26 | |
| 2016-12-31 | $1.94M 10-K · filed 2018-04-02 | $1.54M 10-K/A · filed 2017-04-04 |
| 2016-09-30 | $1.57M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $5.50M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $5.50M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $5.00M 10-Q · filed 2016-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |